glp-1 patent expiration Ozempic, Wegovy and Rybelsus: The patents behind Novo Nordisk's weight-loss drugs Semaglutide Patent Expiry Timeline: A

Those who continued (blue) maintained 17.4% through week 120

Novo Nordisks semaglutide-based treatments, Wegovy and Ozempic, have established a strong market presence

Bazotte, R

Skin redness, itching, mild irritation, and contact dermatitis are common side effects of using a transdermal patch

However, further research has revealed their therapeutic potential across various diseases and health conditions

These distinctions may not be worth considering if youre simply trying to stick to your injection schedule, but if youre trying to glean as much value as possible from your GLP-1 regimen, you need to pay attention to the details